ChemoMetec A/S (CPH:CHEMM)

Market Cap	9.15B
Revenue (ttm)	459.54M
Net Income (ttm)	169.08M
Shares Out	17.40M
EPS (ttm)	9.72
PE Ratio	54.11
Forward PE	41.96
Dividend	4.00 (0.76%)
Ex-Dividend Date	Oct 11, 2024

Volume	578
Average Volume	34,566
Open	520.00
Previous Close	526.00
Day's Range	518.50 - 526.00
52-Week Range	294.60 - 616.00
Beta	1.53
RSI	55.68
Earnings Date	May 7, 2025

About ChemoMetec

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 174
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: CHEMM

Financial Performance

In 2024, ChemoMetec's revenue was 407.87 million, a decrease of -8.22% compared to the previous year's 444.40 million. Earnings were 136.28 million, a decrease of -23.72%.